These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Elevated striatal dopamine and efference copy failure in schizophrenia. Vukadinovic Z Schizophr Res; 2016 Mar; 171(1-3):233-4. PubMed ID: 26817401 [No Abstract] [Full Text] [Related]
8. Evidence for increased dopamine receptor sensitivity in post mortem brains from patients with schizophrenia [proceedings]. Cross AJ; Crow TJ; Longden A; Owen F; Poulter M; Riley GJ J Physiol; 1978 Jul; 280():37P. PubMed ID: 690887 [No Abstract] [Full Text] [Related]
9. PET measurements of dopaminergic pathways in the brain. Perlmutter JS; Moerlein SM Q J Nucl Med; 1999 Jun; 43(2):140-54. PubMed ID: 10429509 [TBL] [Abstract][Full Text] [Related]
10. Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia". Seeman P Neuropsychopharmacology; 1992 Aug; 7(1):55-7; discussion 73-5. PubMed ID: 1388022 [No Abstract] [Full Text] [Related]
12. Recent developments in the neuropharmacology of schizophrenia. Lahti AC; Tamminga CA Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S5-8. PubMed ID: 7749964 [TBL] [Abstract][Full Text] [Related]
13. Dopamine receptors, neuroleptics, and schizophrenia. Snyder SH Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227 [TBL] [Abstract][Full Text] [Related]
14. Dopamine receptors and schizophrenia: the neuroleptic drug problem. Reynolds GP; Riederer P; Jellinger K; Gabriel E Neuropharmacology; 1981 Dec; 20(12B):1319-20. PubMed ID: 6119642 [No Abstract] [Full Text] [Related]
15. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia". Wong DF Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023 [No Abstract] [Full Text] [Related]
16. Central dopaminergic mechanisms in schizophrenia. Owen F; Crow TJ; Poulter M Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760 [TBL] [Abstract][Full Text] [Related]
17. Brain dopamine receptors in schizophrenia and tardive dyskinesia. Seeman P Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008 [TBL] [Abstract][Full Text] [Related]
18. Abnormal neuroleptic/dopamine receptors in schizophrenia. Lee T; Seeman P Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653 [TBL] [Abstract][Full Text] [Related]
19. Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Lee T; Seeman P Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525 [TBL] [Abstract][Full Text] [Related]
20. [Study of the organic substrate of the schizophrenic patient]. De Maio D; Faggioli L Rass Neuropsichiatr; 1967; 21(4):242-59. PubMed ID: 5621601 [No Abstract] [Full Text] [Related] [Next] [New Search]